Arcturus Therapeutics Holdings Inc banner

Arcturus Therapeutics Holdings Inc
NASDAQ:ARCT

Watchlist Manager
Arcturus Therapeutics Holdings Inc Logo
Arcturus Therapeutics Holdings Inc
NASDAQ:ARCT
Watchlist
Price: 7.96 USD -4.67% Market Closed
Market Cap: $226.1m

Intrinsic Value

The intrinsic value of one ARCT stock under the Base Case scenario is hidden USD. Compared to the current market price of 7.96 USD, Arcturus Therapeutics Holdings Inc is hidden .

ARCT Intrinsic Value
HIDDEN
Show

Valuation History
Arcturus Therapeutics Holdings Inc

Intrinsic Value History
Dive into the past to invest in the future

ARCT looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if ARCT is one of them.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about ARCT?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is ARCT valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Arcturus Therapeutics Holdings Inc.

Explain Valuation
Alternatives to ARCT

Wall St
Price Targets

Dividends

Arcturus Therapeutics Holdings Inc
does not pay dividends
Shareholder Yield
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Ownership

ARCT Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one ARCT stock?

The intrinsic value of one ARCT stock under the Base Case scenario is hidden USD.

Is ARCT stock undervalued or overvalued?

Compared to the current market price of 7.96 USD, Arcturus Therapeutics Holdings Inc is hidden .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett